Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Fortress Biotech (FBIO) Assets Average (2016 - 2025)

Fortress Biotech has reported Assets Average over the past 13 years, most recently at $183.5 million for Q4 2025.

  • Quarterly results put Assets Average at $183.5 million for Q4 2025, up 35.25% from a year ago — trailing twelve months through Dec 2025 was $183.5 million (up 35.25% YoY), and the annual figure for FY2025 was $164.9 million, up 5.78%.
  • Assets Average for Q4 2025 was $183.5 million at Fortress Biotech, up from $170.7 million in the prior quarter.
  • Over the last five years, Assets Average for FBIO hit a ceiling of $413.0 million in Q3 2021 and a floor of $135.7 million in Q4 2024.
  • Median Assets Average over the past 5 years was $202.8 million (2023), compared with a mean of $256.3 million.
  • Biggest five-year swings in Assets Average: soared 62.71% in 2021 and later crashed 51.82% in 2023.
  • Fortress Biotech's Assets Average stood at $402.2 million in 2021, then dropped by 23.18% to $308.9 million in 2022, then plummeted by 48.52% to $159.0 million in 2023, then dropped by 14.7% to $135.7 million in 2024, then skyrocketed by 35.25% to $183.5 million in 2025.
  • The last three reported values for Assets Average were $183.5 million (Q4 2025), $170.7 million (Q3 2025), and $169.0 million (Q2 2025) per Business Quant data.